Treatment protocol for newly diagnosed childhood and young adult ALL
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a standard treatment plan (a protocol) for people aged 0 to under 46 with newly diagnosed ALL, a cancer of the blood and bone marrow. It may help by making sure patients receive the right therapy based on their specific ALL subtype.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re newly diagnosed with ALL (B-cell or T-cell type) confirmed by an accredited lab
- You were diagnosed between birth and under age 46 (one day before your 46th birthday)
- Your test results match specific genetic markers: sIG-negative BCP-ALL with IG::MYC (with rules about BCL2/6) or T-ALL with MYC changes
- You must be treated at a participating hospital and live in (or plan to settle in) a participating country
- You (or your parent/guardian) can sign consent following your country’s age rules
- If you can become pregnant (or can father a child), you must have a negative pregnancy test and agree to reliable birth control; no breast-feeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies a treatment plan for people up to age 45 who are newly diagnosed with B-cell or T-cell acute lymphoblastic leukemia (ALL). The goal is to see whether the study treatment improves outcomes compared with standard approaches.
This trial tests a treatment plan for adults aged 18 to 65 who have just been diagnosed with a type of acute lymphoblastic leukemia (ALL) that does not have the Philadelphia chromosome (Ph-negative). The goal is to see how well this therapy works and how safe it is.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This trial tests a treatment plan for people with a certain type of acute lymphoblastic leukemia (ALL) called B-lineage ALL. It aims to see how well the treatment works and how safe it is.
This trial uses a standard treatment plan for children who have just been diagnosed with acute lymphoblastic leukemia (ALL). It aims to guide the best initial treatment for certain cell types of ALL and help improve outcomes while avoiding specific higher-risk subtypes.
This study follows children and teens with newly diagnosed certain leukemia (ALL) and certain favorable brain tumors to learn best care and outcomes. It may help your team compare standard treatments and monitor health over time.
Hear when a new Leukemia, Acute Lymphoblastic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.